(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are PAVmed, Ebix, and Riot Blockchain.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | PAVmed (PAVMW) | 0.03 | 105.67% | 2023-04-11 04:17:06 |
| 2 | Ebix (EBIX) | 18.61 | 23.28% | 2023-04-11 13:57:07 |
| 3 | Riot Blockchain (RIOT) | 12.34 | 16.64% | 2023-04-11 14:03:19 |
| 4 | Marathon (MARA) | 10.49 | 15.27% | 2023-04-11 13:59:00 |
| 5 | Canaan (CAN) | 2.96 | 14.09% | 2023-04-11 14:01:55 |
| 6 | OncoSec Medical Incorporated (ONCS) | 1.27 | 13.39% | 2023-04-10 23:23:15 |
| 7 | StoneCo (STNE) | 10.27 | 13.18% | 2023-04-11 14:03:35 |
| 8 | SmileDirectClub (SDC) | 0.43 | 12.27% | 2023-04-11 14:03:25 |
| 9 | XP (XP) | 12.15 | 11.11% | 2023-04-11 13:36:19 |
| 10 | Organigram Holdings (OGI) | 0.69 | 11.05% | 2023-04-10 23:13:07 |
The three biggest losers today are PLx Pharma, Qutoutiao, and Aspen Group.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | PLx Pharma (PLXP) | 0.19 | -48.25% | 2023-04-11 09:08:09 |
| 2 | Qutoutiao (QTT) | 0.18 | -38.43% | 2023-04-11 13:42:12 |
| 3 | Aspen Group (ASPU) | 0.06 | -12.92% | 2023-04-11 10:30:17 |
| 4 | OpGen (OPGN) | 1.17 | -10.69% | 2023-04-11 01:06:07 |
| 5 | PainReform Ltd. (PRFX) | 0.61 | -10% | 2023-04-11 10:23:18 |
| 6 | Tilray (TLRY) | 2.54 | -7.48% | 2023-04-11 13:50:47 |
| 7 | Ribbon Communications (RBBN) | 3.14 | -6.82% | 2023-04-11 14:23:09 |
| 8 | U.S. Gold Corp (USAU) | 4.90 | -6.31% | 2023-04-11 14:04:03 |
| 9 | Nikola (NKLA) | 1.12 | -6.01% | 2023-04-11 13:49:48 |
| 10 | Newmark Group (NMRK) | 6.76 | -5.06% | 2023-04-10 19:46:15 |
Winners today
1. PAVmed (PAVMW) – 105.67%
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.
NASDAQ ended the session with PAVmed jumping 105.67% to $0.03 on Tuesday while NASDAQ slid 0.43% to $12,031.88.
More news about PAVmed.
2. Ebix (EBIX) – 23.28%
Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia.
NASDAQ ended the session with Ebix rising 23.28% to $18.61 on Tuesday, after two consecutive sessions in a row of gains. NASDAQ fell 0.43% to $12,031.88, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Ebix has a trailing twelve months EPS of $2.1.
PE Ratio
Ebix has a trailing twelve months price to earnings ratio of 8.86. Meaning, the purchaser of the share is investing $8.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.42%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Ebix’s stock is considered to be oversold (<=20).
Volatility
Ebix’s last week, last month’s, and last quarter’s current intraday variation average was a positive 7.18%, a negative 0.19%, and a positive 3.37%.
Ebix’s highest amplitude of average volatility was 9.18% (last week), 4.16% (last month), and 3.37% (last quarter).
Yearly Top and Bottom Value
Ebix’s stock is valued at $18.61 at 17:32 EST, way below its 52-week high of $35.37 and way above its 52-week low of $12.04.
Sales Growth
Ebix’s sales growth is negative 5.9% for the ongoing quarter and negative 12% for the next.
More news about Ebix.
3. Riot Blockchain (RIOT) – 16.64%
Riot Platforms, Inc., together with its subsidiaries, focuses on bitcoin mining operations in North America. It operates through Bitcoin Mining, Data Center Hosting, and Electrical Products and Engineering segments. As of December 31, 2021, it operated approximately 30,907 miners. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is headquartered in Castle Rock, Colorado.
NASDAQ ended the session with Riot Blockchain jumping 16.64% to $12.34 on Tuesday while NASDAQ slid 0.43% to $12,031.88.
Earnings Per Share
As for profitability, Riot Blockchain has a trailing twelve months EPS of $-4.22.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.07%.
Moving Average
Riot Blockchain’s worth is way higher than its 50-day moving average of $6.54 and way above its 200-day moving average of $6.06.
More news about Riot Blockchain.
4. Marathon (MARA) – 15.27%
Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines cryptocurrencies with a focus on the blockchain ecosystem and the generation of digital assets in United States. As of December 31, 2021, it had approximately 8,115 bitcoins, which included the 4,794 bitcoins held in the investment fund. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Marathon rising 15.27% to $10.49 on Tuesday while NASDAQ slid 0.43% to $12,031.88.
Earnings Per Share
As for profitability, Marathon has a trailing twelve months EPS of $-6.9.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -41.77%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marathon’s stock is considered to be oversold (<=20).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 270% and positive 53.8% for the next.
Yearly Top and Bottom Value
Marathon’s stock is valued at $10.49 at 17:32 EST, way below its 52-week high of $29.49 and way higher than its 52-week low of $3.11.
Revenue Growth
Year-on-year quarterly revenue growth declined by 75.5%, now sitting on 149.61M for the twelve trailing months.
Previous days news about Marathon
- Marathon deadline alert. According to Business Insider on Sunday, 9 April, "Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Marathon Digital Holdings Inc. ("Marathon" or the "Company") (NASDAQ: MARA) and reminds investors of the May 30, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.", "Eastern time, and will postpone the publication of its corresponding financial results." That same day, Marathon disclosed receipt of a letter from the U.S. Securities and Exchange Commission relating to accounting errors in the Company’s previously issued financial statements. "
More news about Marathon.
5. Canaan (CAN) – 14.09%
Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components primarily in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has a strategic cooperation with Northern Data AG in the areas of artificial intelligence development, blockchain technology, and datacenter operations. Canaan Inc. was founded in 2013 and is based in Beijing, the People's Republic of China.
NASDAQ ended the session with Canaan jumping 14.09% to $2.96 on Tuesday while NASDAQ slid 0.43% to $12,031.88.
Earnings Per Share
As for profitability, Canaan has a trailing twelve months EPS of $0.56.
PE Ratio
Canaan has a trailing twelve months price to earnings ratio of 5.28. Meaning, the purchaser of the share is investing $5.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 62.53%.
Moving Average
Canaan’s value is above its 50-day moving average of $2.95 and below its 200-day moving average of $3.13.
Yearly Top and Bottom Value
Canaan’s stock is valued at $2.96 at 17:32 EST, way below its 52-week high of $6.60 and way above its 52-week low of $1.87.
Volume
Today’s last reported volume for Canaan is 4806540 which is 109.09% above its average volume of 2298790.
More news about Canaan.
6. OncoSec Medical Incorporated (ONCS) – 13.39%
OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 (IL-12) for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in Phase IIb clinical trials (KEYNOTE-695) and advanced or metastatic triple negative breast cancer (TNBC), which is in Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials. In addition, the company is developing monotherapy biomarker study in patients with advanced or metastatic TNBC that has completed the Phase II clinical trials; and new DNA-encoded therapeutic candidates and tumor indications to treat deep visceral lesions, such as liver, lung, bladder, pancreatic, and other visceral lesions. It has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890 studies; a research collaboration with Duke University's Center for Applied Therapeutics to evaluate enhanced IL-12 DNA-plasmid; a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate the use of Roswell Park's intravital microscopy and enhanced IL-12 DNA-plasmid; and collaboration with Providence Cancer Institute. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated was founded in 2008 and is headquartered in Pennington, New Jersey.
NASDAQ ended the session with OncoSec Medical Incorporated jumping 13.39% to $1.27 on Tuesday, following the last session’s upward trend. NASDAQ slid 0.43% to $12,031.88, following the last session’s downward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, OncoSec Medical Incorporated has a trailing twelve months EPS of $-1.708.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -233.38%.
Moving Average
OncoSec Medical Incorporated’s value is way under its 50-day moving average of $1.85 and way below its 200-day moving average of $7.75.
Volume
Today’s last reported volume for OncoSec Medical Incorporated is 27590100 which is 919.58% above its average volume of 2706020.
More news about OncoSec Medical Incorporated.
7. StoneCo (STNE) – 13.18%
StoneCo Ltd. provides financial technology solutions to merchants and integrated partners to conduct electronic commerce across in-store, online, and mobile channels in Brazil. It distributes its solutions, principally through proprietary Stone Hubs, which offer hyper-local sales and services; and technology and solutions to digital merchants through sales and technical personnel and software vendors, as well as sells solutions to brick-and-mortar and digital merchants through sales team. As of December 31, 2021, the company served approximately 1,766,100 clients primarily small-and-medium-sized businesses; and marketplaces, e-commerce platforms, and integrated software vendors. StoneCo Ltd. was founded in 2000 and is headquartered in George Town, the Cayman Islands.
NASDAQ ended the session with StoneCo jumping 13.18% to $10.27 on Tuesday, following the last session’s upward trend. NASDAQ fell 0.43% to $12,031.88, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, StoneCo has a trailing twelve months EPS of $-0.33.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.31%.
Volume
Today’s last reported volume for StoneCo is 8660660 which is 69.66% above its average volume of 5104480.
Yearly Top and Bottom Value
StoneCo’s stock is valued at $10.27 at 17:32 EST, way under its 52-week high of $13.13 and way higher than its 52-week low of $6.81.
More news about StoneCo.
8. SmileDirectClub (SDC) – 12.27%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub rising 12.27% to $0.43 on Tuesday while NASDAQ dropped 0.43% to $12,031.88.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.628.
Yearly Top and Bottom Value
SmileDirectClub’s stock is valued at $0.43 at 17:32 EST, way below its 52-week high of $3.10 and way higher than its 52-week low of $0.32.
Moving Average
SmileDirectClub’s worth is way under its 50-day moving average of $0.53 and way under its 200-day moving average of $0.88.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 16% and 26.3%, respectively.
Volume
Today’s last reported volume for SmileDirectClub is 1314340 which is 46.86% below its average volume of 2473720.
More news about SmileDirectClub.
9. XP (XP) – 11.11%
XP Inc. provides financial products and services in Brazil. It offers securities brokerage, private pension plans, commercial, and investment banking products, such as loan operations and transactions in the foreign exchange markets and deposits; product structuring and capital markets services for corporate clients and issuers of fixed income products; advisory services for mass-affluent and institutional clients; and wealth management services for high-net-worth customers and institutional clients. The company also offers Xpeed, an online financial education portal that offers seminars, classes, and learning tools to help teach individuals on topics, such as basics of investing, techniques, and investment strategies, as well as insurance brokerage services. In addition, it operates XP Platform, an open product platform that provides clients to access investment products in the market, including equity and fixed income securities, mutual and hedge funds, private equity, structured products, credit cards, loan operations, life insurance, pension plans, real-estate investment funds, and others. The company was founded in 2001 and is based in São Paulo, Brazil.
NASDAQ ended the session with XP rising 11.11% to $12.15 on Tuesday, after two successive sessions in a row of gains. NASDAQ fell 0.43% to $12,031.88, following the last session’s downward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, XP has a trailing twelve months EPS of $1.19.
PE Ratio
XP has a trailing twelve months price to earnings ratio of 12.33. Meaning, the purchaser of the share is investing $12.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.52%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 13.12B for the twelve trailing months.
Volatility
XP’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.33%, a negative 0.11%, and a positive 3.00%.
XP’s highest amplitude of average volatility was 1.25% (last week), 2.78% (last month), and 3.00% (last quarter).
Moving Average
XP’s worth is way under its 50-day moving average of $14.42 and way below its 200-day moving average of $17.54.
More news about XP.
10. Organigram Holdings (OGI) – 11.05%
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
NASDAQ ended the session with Organigram Holdings jumping 11.05% to $0.69 on Tuesday while NASDAQ dropped 0.43% to $12,031.88.
Earnings Per Share
As for profitability, Organigram Holdings has a trailing twelve months EPS of $-0.02.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.53%.
Sales Growth
Organigram Holdings’s sales growth is 34.3% for the ongoing quarter and 12.7% for the next.
More news about Organigram Holdings.
Losers Today
1. PLx Pharma (PLXP) – -48.25%
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.
NASDAQ ended the session with PLx Pharma sliding 48.25% to $0.19 on Tuesday while NASDAQ dropped 0.43% to $12,031.88.
Earnings Per Share
As for profitability, PLx Pharma has a trailing twelve months EPS of $-2.46.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -75.18%.
More news about PLx Pharma.
2. Qutoutiao (QTT) – -38.43%
Qutoutiao Inc. operates mobile platforms for the distribution, consumption, and sharing of light entertainment content in the People's Republic of China. The company operates Qutoutiao, a mobile application that aggregates articles and videos from content providers and presents real-time customized feeds to users, as well as provides online data processing and transaction processing services. It also offers Midu Novels, a mobile literature application that offers users free literature supported by advertising, as well as Midu Lite mobile literature application. The company was formerly known as Qtech Ltd. and changed its name to Qutoutiao Inc. in July 2018. Qutoutiao Inc. was founded in 2016 and is headquartered in Shanghai, China.
NASDAQ ended the session with Qutoutiao falling 38.43% to $0.18 on Tuesday, after five successive sessions in a row of losses. NASDAQ slid 0.43% to $12,031.88, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Qutoutiao has a trailing twelve months EPS of $-1.79.
Moving Average
Qutoutiao’s worth is way below its 50-day moving average of $0.68 and way below its 200-day moving average of $0.74.
Revenue Growth
Year-on-year quarterly revenue growth declined by 32.3%, now sitting on 4.34B for the twelve trailing months.
Volume
Today’s last reported volume for Qutoutiao is 3267770 which is 1804.63% above its average volume of 171570.
Yearly Top and Bottom Value
Qutoutiao’s stock is valued at $0.18 at 17:32 EST, way under its 52-week high of $2.34 and way higher than its 52-week low of $0.15.
Previous days news about Qutoutiao
- Delisting of securities of core scientific, inc.; the very good food company inc.; hyrecar inc.; reeds, inc.; sorrento therapeutics, inc.; cyren ltd.; lucira health, inc.; qutoutiao inc.; and sio gene therapies inc. from the nasdaq stock market. According to GlobeNewsWire on Monday, 10 April, "Nasdaq also announced today that it will delist the American Depositary Shares of Qutoutiao Inc. Qutoutiao Inc. shares were suspended on March 23, 2023, and have not traded on Nasdaq since that time."
More news about Qutoutiao.
3. Aspen Group (ASPU) – -12.92%
Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.
NASDAQ ended the session with Aspen Group sliding 12.92% to $0.06 on Tuesday, following the last session’s upward trend. NASDAQ slid 0.43% to $12,031.88, following the last session’s downward trend on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Aspen Group has a trailing twelve months EPS of $-0.62.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.28%.
Volume
Today’s last reported volume for Aspen Group is 4735 which is 99.51% below its average volume of 977605.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aspen Group’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
Aspen Group’s stock is valued at $0.06 at 17:32 EST, way under its 52-week high of $1.39 and way higher than its 52-week low of $0.03.
More news about Aspen Group.
4. OpGen (OPGN) – -10.69%
OpGen, Inc., a precision medicine company, engages in developing molecular information products and services in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company's products include Acuitas AMR Gene Panel, a vitro diagnostic test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen; and QuickFISH and PNA FISH diagnostic test products for the identification of various infectious pathogens, as well as SARS CoV-2 test kits. In addition, it offers Acuitas Lighthouse informatics systems, a cloud-based HIPAA compliant informatics, which combines clinical lab test results with patient and hospital information to provide analytics and insights to enable manage MDROs in the hospital and patient care environment; Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers; and ARES Technology Platform, including ARESdb, which provides next generation sequencing based and artificial intelligence powered, cloud-based bioinformatics solutions to generate AMR profiles, as well as predict antimicrobial susceptibility test results. OpGen, Inc. has a strategic collaboration with the New York State Department of Health to develop a solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
NASDAQ ended the session with OpGen sliding 10.69% to $1.17 on Tuesday, after two consecutive sessions in a row of losses. NASDAQ slid 0.43% to $12,031.88, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, OpGen has a trailing twelve months EPS of $-15.04.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -152.82%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 49.4%, now sitting on 2.61M for the twelve trailing months.
Volume
Today’s last reported volume for OpGen is 203108 which is 57.45% below its average volume of 477450.
More news about OpGen.
5. PainReform Ltd. (PRFX) – -10%
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
NASDAQ ended the session with PainReform Ltd. sliding 10% to $0.61 on Tuesday while NASDAQ dropped 0.43% to $12,031.88.
Earnings Per Share
As for profitability, PainReform Ltd. has a trailing twelve months EPS of $-0.686.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.74%.
Moving Average
PainReform Ltd.’s value is higher than its 50-day moving average of $0.58 and below its 200-day moving average of $0.63.
Volume
Today’s last reported volume for PainReform Ltd. is 1996 which is 99.33% below its average volume of 298131.
More news about PainReform Ltd..
6. Tilray (TLRY) – -7.48%
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
NASDAQ ended the session with Tilray dropping 7.48% to $2.54 on Tuesday while NASDAQ dropped 0.43% to $12,031.88.
Here's what key metrics tell us about tilray brands, inc. (tlry) Q3 earningsHere is how Tilray Brands, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:, View all Key Company Metrics for Tilray Brands, Inc. here>>>Shares of Tilray Brands, Inc. have returned +7.4% over the past month versus the Zacks S&P 500 composite’s +3.1% change.
: tilray, hexo stocks fall sharply after m&a dealHexo shareholders will receive 0.4352 of a share of Tilray for each Hexo share, for an implied purchase price of $1.25 per Hexo share based on the volume weighted average price of Tilray on the Nasdaq for the 60-day period ended on April 5.
Earnings Per Share
As for profitability, Tilray has a trailing twelve months EPS of $-1.07.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.9%.
Yearly Top and Bottom Value
Tilray’s stock is valued at $2.54 at 17:32 EST, way under its 52-week high of $9.08 and way higher than its 52-week low of $2.28.
Volatility
Tilray’s last week, last month’s, and last quarter’s current intraday variation average was 4.11%, 0.77%, and 2.97%.
Tilray’s highest amplitude of average volatility was 5.14% (last week), 2.79% (last month), and 2.97% (last quarter).
Previous days news about Tilray
- Is tilray brands (tlry) A buy ahead of fiscal Q3 earnings announcement?. According to Zacks on Monday, 10 April, "One of the original meme stocks Tilray Brands (TLRY Quick QuoteTLRY – Free Report) is set to report fiscal third-quarter earnings results on Monday after the close. "
- Tilray brands, inc. (tlry) reports Q3 loss, lags revenue estimates. According to Zacks on Monday, 10 April, "While Tilray Brands, Inc. Has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?", "Ahead of this earnings release, the estimate revisions trend for Tilray Brands, Inc. Unfavorable. "
More news about Tilray.
7. Ribbon Communications (RBBN) – -6.82%
Ribbon Communications Inc. provides communications technology in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates through two segments, Cloud and Edge, and IP Optical Networks. The Cloud and Edge segment provides software and hardware products; and solutions and services for enabling voice over internet protocol communications, voice over long-term evolution, and voice over 5G communications and unified communications and collaboration. It also offers session border controller and network transformation products. This segment serves private, public, or hybrid cloud infrastructures, as well as data centers, enterprise premises, and service provider networks. It also provides multiple solutions for VoIP, VoLTE, VoNR, and UC&C in network, on-premises, or via the telco cloud. The IP Optical Networks segment provides hardware and software solutions for IP networking, switching, routing, and optical transport to support and enable technologies, such as 5G, distributed cloud computing, and corresponding applications. It also offers multiple solutions, including 5G-native solutions for mobile-backhaul, metro and edge aggregation, core networking, data center interconnect, legacy NTR, and transport solutions for wholesale carriers. This segment serves utilities, government, defense, finance, transportation, and education and research industries, as well as service providers and enterprises. It also provides advanced analytics solutions and next generation products that provides cloud-native and streaming analytics platform for networks and subscribers. The company was formerly known as Sonus Networks, Inc. and changed its name to Ribbon Communications Inc. in November 2017. Ribbon Communications Inc. was founded in 1997 and is headquartered in Plano, Texas.
NASDAQ ended the session with Ribbon Communications sliding 6.82% to $3.14 on Tuesday, following the last session’s downward trend. NASDAQ slid 0.43% to $12,031.88, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Ribbon Communications has a trailing twelve months EPS of $-0.63.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.76%.
More news about Ribbon Communications .
8. U.S. Gold Corp (USAU) – -6.31%
U.S. Gold Corp. engages in the exploration and development of gold and precious metals in the United States. It also explores for copper and silver deposits. The company holds 100% interests in the CK Gold project, which consists of various mining leases and other mineral rights covering approximately 1,120 acres in Laramie County, Wyoming; the Keystone project that consists of 650 unpatented lode mining claims covering approximately 20 square miles in Eureka County, Nevada; and the Challis Gold project, which consists of 87 unpatented lode mining claims covering approximately 1,710 acres in Lemhi County, Idaho. It also has earn-in agreement to acquire a 50% ownership interest in the Maggie Creek project that consists of 103 unpatented mining claims covering approximately 3 square miles in Eureka County, Nevada. The company is based in Elko, Nevada.
NASDAQ ended the session with U.S. Gold Corp sliding 6.31% to $4.90 on Tuesday, after two sequential sessions in a row of losses. NASDAQ slid 0.43% to $12,031.88, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, U.S. Gold Corp has a trailing twelve months EPS of $-0.81.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -45.57%.
Moving Average
U.S. Gold Corp’s worth is way higher than its 50-day moving average of $4.41 and way above its 200-day moving average of $4.17.
Volume
Today’s last reported volume for U.S. Gold Corp is 224723 which is 165.62% above its average volume of 84601.
More news about U.S. Gold Corp.
9. Nikola (NKLA) – -6.01%
Nikola Corporation operates as a technology innovator and integrator that works to develop energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery hydrogen-electric and battery-electric semi-trucks to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation is headquartered in Phoenix, Arizona.
NASDAQ ended the session with Nikola sliding 6.01% to $1.12 on Tuesday while NASDAQ fell 0.43% to $12,031.88.
Earnings Per Share
As for profitability, Nikola has a trailing twelve months EPS of $-1.731.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -113.47%.
Volatility
Nikola’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.84%, a negative 1.97%, and a positive 4.72%.
Nikola’s highest amplitude of average volatility was 3.69% (last week), 5.67% (last month), and 4.72% (last quarter).
Sales Growth
Nikola’s sales growth for the next quarter is 2539.1%.
Yearly Top and Bottom Value
Nikola’s stock is valued at $1.12 at 17:32 EST, way below its 52-week low of $1.35.
Volume
Today’s last reported volume for Nikola is 25754700 which is 76.67% above its average volume of 14577600.
More news about Nikola.
10. Newmark Group (NMRK) – -5.06%
Newmark Group, Inc. provides commercial real estate services in the United States and internationally. The company's investor/owner services and products include capital markets, such as investment, debt and structured finance, and loan sales; agency leasing, property management, and valuation and advisory; and commercial real estate due diligence consulting and advisory services, as well as government sponsored enterprise lending, loan servicing, mortgage broking, and equity-raising services. Its occupier services and products comprise tenant representation; real estate management technology systems; workplace and occupancy strategy; global corporate consulting; project management; and lease administration and facilities management services. The company provides its services to commercial real estate tenants, investors, owners, occupiers, and developers. As of December 31, 2020, it operated approximately 480 offices on six continents. The company was formerly known as Newmark Knight Frank and changed its name to Newmark Group, Inc. in October 2017. Newmark Group, Inc. was founded in 1929 and is based in New York, New York.
NASDAQ ended the session with Newmark Group sliding 5.06% to $6.76 on Tuesday while NASDAQ slid 0.43% to $12,031.88.
Earnings Per Share
As for profitability, Newmark Group has a trailing twelve months EPS of $0.45.
PE Ratio
Newmark Group has a trailing twelve months price to earnings ratio of 17.33. Meaning, the purchaser of the share is investing $17.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.98%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 50.8% and a negative 36.1%, respectively.
Volume
Today’s last reported volume for Newmark Group is 2131970 which is 129.5% above its average volume of 928941.
More news about Newmark Group.
Stay up to date with our winners and losers daily report
